Drawing for INFUBASE

USPTO serial 88289949

INFUBASE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SOUDERS, MICHAEL J
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INFUBASE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. TROUTMAN SANDERS LLP875 THIRD AVENUEC/O IPSERVICES NYCNEW YORK, NY 10022

Goods and services

ClassDescriptionStatusFirst use
010Medical devices, namely, vial access system consisting primarily of a docking tray that facilitates direct access to contents of multiple vialsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 15, 2022MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Nov 15, 2022ABN5ABANDONMENT - AFTER PUBLICATION—
Nov 14, 2022EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 11, 2022EX5GSOU EXTENSION 5 GRANTED—
May 11, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 4, 2022EXT5SOU EXTENSION 5 FILED—
May 4, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 21, 2021EX4GSOU EXTENSION 4 GRANTED—
Oct 21, 2021EXT4SOU EXTENSION 4 FILED—
Oct 21, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 13, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 11, 2021EX3GSOU EXTENSION 3 GRANTED—
May 11, 2021EXT3SOU EXTENSION 3 FILED—
May 11, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 23, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 21, 2020EX2GSOU EXTENSION 2 GRANTED—
Dec 21, 2020EXT2SOU EXTENSION 2 FILED—
Dec 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 13, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 11, 2020EX1GSOU EXTENSION 1 GRANTED—
May 11, 2020EXT1SOU EXTENSION 1 FILED—
May 11, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 3, 2019ALIEASSIGNED TO LIE—
Sep 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2019DOCKASSIGNED TO EXAMINER—
Feb 27, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 8, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance